Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $590.79 | 13 | 86.9% |
| Education | $89.10 | 1 | 13.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $212.89 | 3 | $0 (2023) |
| Alcon Laboratories Inc | $182.64 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $89.10 | 1 | $0 (2017) |
| Glaukos Corporation | $46.70 | 1 | $0 (2017) |
| Allergan, Inc. | $44.87 | 2 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $39.01 | 2 | $0 (2018) |
| Johnson & Johnson Surgical Vision, Inc. | $29.24 | 1 | $0 (2021) |
| Horizon Therapeutics plc | $23.73 | 1 | $0 (2021) |
| Shire North American Group Inc | $11.71 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.96 | 1 | Galderma Laboratories, L.P. ($20.96) |
| 2021 | $52.97 | 2 | Johnson & Johnson Surgical Vision, Inc. ($29.24) |
| 2020 | $44.87 | 2 | Allergan, Inc. ($44.87) |
| 2019 | $124.95 | 1 | Galderma Laboratories, L.P. ($124.95) |
| 2018 | $117.70 | 4 | Galderma Laboratories, L.P. ($66.98) |
| 2017 | $318.44 | 4 | Alcon Laboratories Inc ($182.64) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2023 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| 10/26/2021 | Johnson & Johnson Surgical Vision, Inc. | — | Food and Beverage | In-kind items and services | $29.24 | General |
| 02/09/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: KRYSTEXXA | ||||||
| 12/28/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| 12/21/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| 06/12/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $124.95 | General |
| 10/05/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: OPTHALMICS | ||||||
| 09/22/2018 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $66.98 | General |
| 07/16/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BEPREVE, LOTEMAX GEL | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/04/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BEPREVE, LOTEMAX GEL | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/27/2017 | Glaukos Corporation | ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $46.70 | General |
| Category: Glaucoma | ||||||
| 08/13/2017 | Alcon Laboratories Inc | ReSTOR (Device) | Food and Beverage | In-kind items and services | $84.22 | General |
| Category: Ophthalmology | ||||||
| 08/11/2017 | Alcon Laboratories Inc | AcrySof (Device) | Food and Beverage | In-kind items and services | $98.42 | General |
| Category: Ophthalmology | ||||||
| 06/09/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Education | In-kind items and services | $89.10 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 759 | 833 | $483,120 | $105,757 |
| 2022 | 9 | 634 | 694 | $271,440 | $77,801 |
| 2021 | 5 | 317 | 347 | $161,925 | $43,385 |
| 2020 | 3 | 143 | 166 | $59,040 | $15,351 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 55 | 55 | $146,055 | $32,849 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 187 | $31,545 | $15,764 | 50.0% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2023 | 22 | 24 | $89,500 | $10,590 | 11.8% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 29 | 29 | $80,820 | $8,794 | 10.9% |
| 15730 | Creation of flap graft to midface | Facility | 2023 | 13 | 13 | $33,400 | $8,635 | 25.9% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 14 | 14 | $26,720 | $8,448 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 126 | $16,140 | $7,616 | 47.2% |
| 92285 | Photography of content of eyes | Office | 2023 | 285 | 326 | $33,680 | $5,147 | 15.3% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 30 | 32 | $15,420 | $3,666 | 23.8% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 12 | 12 | $5,640 | $2,549 | 45.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,200 | $1,699 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 163 | $27,355 | $14,845 | 54.3% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 24 | 24 | $53,275 | $14,786 | 27.8% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Office | 2022 | 21 | 21 | $58,060 | $13,821 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 133 | $18,510 | $8,653 | 46.7% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 11 | 12 | $24,920 | $7,652 | 30.7% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2022 | 13 | 13 | $36,940 | $4,753 | 12.9% |
| 92285 | Photography of content of eyes | Office | 2022 | 234 | 268 | $27,960 | $4,467 | 16.0% |
| 68840 | Probing of nasal tear duct | Office | 2022 | 32 | 32 | $13,305 | $3,975 | 29.9% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 13 | 14 | $7,130 | $3,064 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,985 | $1,785 | 44.8% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Office | 2021 | 22 | 22 | $62,995 | $14,411 | 22.9% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2021 | 17 | 17 | $49,810 | $10,931 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 107 | $19,795 | $9,984 | 50.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 49 | $7,025 | $3,151 | 44.8% |
About Dr. Eric Hamill, M.D
Dr. Eric Hamill, M.D is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1871905463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Hamill, M.D has received a total of $679.89 in payments from pharmaceutical and medical device companies, with $20.96 received in 2023. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($590.79).
As a Medicare-enrolled provider, Hamill has provided services to 1,853 Medicare beneficiaries, totaling 2,040 services with total Medicare billing of $242,294. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Location Houston, TX
- Active Since 05/29/2014
- Last Updated 11/05/2020
- Taxonomy Code 207WX0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871905463
Products in Payments
- AcrySof (Device) $98.42
- EYLEA AFLIBERCEPT INJECTION (Biological) $89.10
- ReSTOR (Device) $84.22
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $46.70
- BOTOX COSMETIC (Biological) $44.87
- VYZULTA (Drug) $39.01
- KRYSTEXXA (Biological) $23.73
- DYSPORT (Biological) $20.96
- XIIDRA (Drug) $11.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmic Plastic and Reconstructive Surgery Doctors in Houston
Dr. Sherif Khalil, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $3,125
Dr. Charles Soparkar, M.d., Ph.d, M.D., PH.D
Ophthalmic Plastic and Reconstructive Surgery — Payments: $2,711
George Villatoro, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $1,543
Katherine Williams, M.d, M.D
Ophthalmic Plastic and Reconstructive Surgery — Payments: $706.33
Dr. Kenneth Hyde, M.d, M.D
Ophthalmic Plastic and Reconstructive Surgery — Payments: $440.37
Dr. Oded Sagiv, M.d, M.D
Ophthalmic Plastic and Reconstructive Surgery — Payments: $180.13